Board Meeting on Oct 23 to consider Q2 and H1 FY26 results

Revenue growth above 20%Exceptional itemResults View source PDF Explain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹4766.50

prior close

₹4765.00

announcement price

After-mkt

timing

Nifty 100market-0.8%-0.8% vs market

Pharmaceuticals peers, median of 170sector-0.3%-1.3% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty 100 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

-0.1

15m

-0.2

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-0.8-0.8-0.3-1.3

Next day

-3.1-2.6-0.6-2.7-0.4

-2.6-1.4-1.2-2.7+0.1

-1.8-1.9+0.1-2.6+0.9

-2.9-0.5-2.5-3.1+0.2

-4.1-0.8-3.3-2.9-1.1

-4.4+1.1-5.4-3.4-0.9

15d

-3.9+0.1-4.0-3.4-0.5

—————

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Torrent Pharmaceuticals has informed BSE and NSE of a Board Meeting scheduled for Friday, 23 October 2026. The Board will consider and approve the Audited Financial Results on a standalone basis and the Unaudited Financial Results (with limited review) on a consolidated basis for the quarter and half year ended 30 September 2026. This is a routine Regulation 29 disclosure and no financial numbers were shared in this intimation.

Likely market impact

Investors should watch for Q2 and H1 FY26 results on 23 October; no price-moving details are available in this advance notice yet.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹4,979 Cr	₹3,302 Cr	+50.8%
Operating profit	₹757.0 Cr	₹831.0 Cr	−8.9%
Profit after tax	₹534.0 Cr	₹591.0 Cr	−9.6%
EBITDA margin	33.3%	32.4%	+0.9 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.